These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27339628)

  • 1. Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.
    Yoon S; Kang BW; Park SY; Kim HJ; Park JS; Choi GS; Kim JG
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1775-80. PubMed ID: 27339628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.
    Stremitzer S; Sunakawa Y; Zhang W; Yang D; Ning Y; Stintzing S; Sebio A; Yamauchi S; Matsusaka S; El-Khoueiry R; Stift J; Wrba F; Gruenberger T; Lenz HJ
    Pharmacogenomics J; 2015 Dec; 15(6):521-9. PubMed ID: 25752522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
    Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
    Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Jeon HS; Lee WK; Kim JG
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S634-9. PubMed ID: 24770722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
    Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility variants associated with colorectal cancer prognosis.
    Abulí A; Lozano JJ; Rodríguez-Soler M; Jover R; Bessa X; Muñoz J; Esteban-Jurado C; Fernández-Rozadilla C; Carracedo A; Ruiz-Ponte C; Cubiella J; Balaguer F; Bujanda L; Reñé JM; Clofent J; Morillas JD; Nicolás-Pérez D; Xicola RM; Llor X; Piqué JM; Andreu M; Castells A; Castellví-Bel S;
    Carcinogenesis; 2013 Oct; 34(10):2286-91. PubMed ID: 23712746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
    Garziera M; Bidoli E; Cecchin E; Mini E; Nobili S; Lonardi S; Buonadonna A; Errante D; Pella N; D'Andrea M; De Marchi F; De Paoli A; Zanusso C; De Mattia E; Tassi R; Toffoli G
    PLoS One; 2015; 10(12):e0144000. PubMed ID: 26633805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
    Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
    Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
    Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
    Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
    Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
    Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
    PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the polymorphisms in the hypoxia pathway genes in relation to outcome in colorectal cancer.
    Haja Mohideen AM; Hyde A; Squires J; Wang J; Dicks E; Younghusband B; Parfrey P; Green R; Savas S
    PLoS One; 2014; 9(11):e113513. PubMed ID: 25405996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
    Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
    Szkandera J; Knechtel G; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Langsenlehner T; Dehchamani D; Samonigg H; Renner W; Gerger A
    Anticancer Res; 2010 Jun; 30(6):2393-7. PubMed ID: 20651398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer.
    Chae YS; Kim JG; Kang BW; Lee SJ; Lee YJ; Park JS; Choi GS; Lee WK; Jeon HS
    Anticancer Res; 2013 Feb; 33(2):513-9. PubMed ID: 23393343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
    Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
    PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.